BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6199132)

  • 1. Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck.
    Espana P; Smith F; Abrams J; Haidak D; Ueno W; Woolley P; Schein P
    Cancer Chemother Pharmacol; 1984; 12(2):98-100. PubMed ID: 6199132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
    Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
    Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck.
    Davis S; Kessler W
    Cancer Chemother Pharmacol; 1979; 3(1):57-9. PubMed ID: 93988
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].
    Jahnke V
    HNO; 1980 Dec; 28(12):405-8. PubMed ID: 6161913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced epidermoid carcinoma of the head and neck using methotrexate, bleomycin and cis-platinum.
    Orsini MA; Strauss M; Zaino RJ; Messeih AA; Harvey HA; Lipton A
    Trans Pa Acad Ophthalmol Otolaryngol; 1984; 37(1):71-6. PubMed ID: 6204427
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination chemotherapy with cisplatin, bleomycin, and methotrexate in patients with advanced head and neck cancer.
    Von Hoff DD; Alberts DS; Mattox DE; Coulthard S; Dana B; Manning M; Myers JW; Griffin CB
    Cancer Clin Trials; 1981; 4(2):215-8. PubMed ID: 6166408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
    Drelichman A; Cummings G; Al-Sarraf M
    Cancer; 1983 Aug; 52(3):399-403. PubMed ID: 6190548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleomycin and cis-platinum with or without mitomycin C in 110 previously untreated patients with head and neck cancer.
    Israel L; Aguilera J; Soudant J; Penot JC; Breau JL; Morere JF
    Am J Clin Oncol; 1983 Jun; 6(3):305-11. PubMed ID: 6189388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of head and neck cancer: combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin.
    Wittes RE; Spiro RH; Shah J; Gerold FP; Koven B; Strong EW
    Med Pediatr Oncol; 1977; 3(3):301-9. PubMed ID: 85249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of advanced head and neck cancer with a combination of bleomycin, vincristine, methotrexate and hydroxyuree or cis-dichloro-diamino-platinium. Analysis of local and general parameters of prognosis (author's transl)].
    Pouillart P; Palangie T; Garcia-Giralt E; Jouve M; Bataini JP; Jaulerry M; Brugère J; Asselin B
    Bull Cancer; 1980; 67(3):269-80. PubMed ID: 6157447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Randomized trial of vincristin-methotrexate-bleomycin and cis-platin or detorubicin for advanced head and neck cancer (author's transl)].
    Cappelaere P; Chauvergne J; Klein T; Gary-Bobo J; Guerrin J; Meeus L
    Bull Cancer; 1981; 68(5):422-7. PubMed ID: 6174165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
    Ervin TJ; Weichselbaum R; Miller D; Meshad M; Posner M; Fabian R
    Cancer Treat Rep; 1981; 65(9-10):787-91. PubMed ID: 6168371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary results of a chemotherapy study of patients with squamous cell carcinoma in the head and neck region. Comparison of 2 therapeutic regimens: cis-diamminodichloroplatinum (II) and bleomycin compared to methotrexate and vindesine].
    von Heyden HW; Beyer JH; Matthaei A; Nagel GA; Schröder M
    Onkologie; 1981 Dec; 4(6):296-9. PubMed ID: 6175933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
    Clavel M; Cognetti F; Dodion P; Wildiers J; Rosso R; Rossi A; Gignoux B; Van Rymenant M; Cortes-Funes H; Dalesio O
    Cancer; 1987 Sep; 60(6):1173-7. PubMed ID: 2441836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined chemotherapy of head and neck squamous cell carcinomas with methotrexate, bleomycin, and hydroxyurea.
    Medenica R; Alberto P; Lehmann W
    Cancer Chemother Pharmacol; 1981; 5(3):145-9. PubMed ID: 6170472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient schedule.
    Vogl SE; Kaplan BH
    Cancer; 1979 Jul; 44(1):26-31. PubMed ID: 88256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
    Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH
    Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic effects of cis-platinum-bleomycin therapy.
    Najarian T; Miller A; Zimelman AP; Ki Hong W
    Oncology; 1981; 38(4):195-7. PubMed ID: 6165944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.